Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells
ME (Emmy) M Dolman1, Stefan Harmsen1, Ebel HE Pieters1, Rolf W Sparidans2, Marie Lacombe3, Bálint Szokol4, László Orfi4, György Kéri4, Gert Storm1, Wim E Hennink1, Robbert J Kok11Department of Pharmaceutics, Utrecht Institute f...
Guardado en:
Autores principales: | Dolman MEM, Harmsen S, Pieters EHE, Sparidans RW, Lacombe M, Szokol B, Őrfi L, Kéri G, Storm G, Hennink WE, Kok RJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3607798464b4a16907ee9b6f6541fb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Chemical and Electrochemical Synthesis of Platinum Black
por: S. E. Stanca, et al.
Publicado: (2017)
por: S. E. Stanca, et al.
Publicado: (2017)
Ejemplares similares
-
Application of liposomal technologies for delivery of platinum analogs in oncology
por: Liu D, et al.
Publicado: (2013) -
Sunitinib for advanced renal cell cancer
por: Chris Coppin
Publicado: (2008) -
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
por: Hiroki Tsujinaka, et al.
Publicado: (2020) -
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
por: Crielaard BJ, et al.
Publicado: (2011) -
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
por: Stephan Ursprung, et al.
Publicado: (2021)